一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Ganirelix Acetate

Ganirelix Acetate Struktur
123246-29-7
CAS-Nr.
123246-29-7
Englisch Name:
Ganirelix Acetate
Synonyma:
GANIRELIX;Ganirelixum;5-?dihydroxy-;3-?bis[[3-?(3;ganirelix Acetate;Ganirelix DiAcetate;Ganirelix Impurity 1;Ganirelix Acetate API;Ganirelix Acetate USP/EP/BP;4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
CBNumber:
CB61370494
Summenformel:
C80H113ClN18O13
Molgewicht:
1570.34
MOL-Datei:
123246-29-7.mol

Ganirelix Acetate Eigenschaften

Sequenz
Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-Tyr-D-Har(Et2)-Leu-Har(Et2)-Pro-DAla-NH2
InChIKey
GJNXBNATEDXMAK-HJHIFQDRNA-N

Sicherheit

HS Code  3504009000

Ganirelix Acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

Antagon,Organon

Therapeutic Function

LHRH antagonist

Clinical Use

Ganirelix acetate is an analog of GnRH with substitutions at residues 1, 2, 3, 6, 8, and 10. It is not a superagonist but, rather, is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. It is approved for the suppression of LH surges in women who are undergoing ovarian hyperstimulation fertility treatment; LH surges normally promote ovulation. The goal of this drug is to significantly reduce the number of medication days necessary to suppress the LH surge, thereby maintaining eggs in the ovaries. In vitro fertilization (IVF) treatment cycles were historically initiated by the administration of leuprolide acetate to suppress the premature release of LH. This inhibits ovulation so that the eggs remain available for retrieval by a fertility specialist. For this purpose, leuprolide acetate usually is injected for as many as 26 days. Clinical studies have shown that ganirelix acetate can shut down the LH surge in only 5 days of treatment, that the suppression of LH is more pronounced than that of FSH, and that the shorter treatment time minimizes unpleasant side effects, such as hot flashes and headaches.

Ganirelix Acetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ganirelix Acetate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 216)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Affida new material science and technology center
+undefined15081010295
admin@oudaxin.com China 114 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618092446649
sarah@tnjone.com China 1143 58
Chongqing Soarwin Technology Co., Ltd
+86-15790943001
crystal@sorawin.cn China 421 58
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
+86-13017695106 +86-13676922317
jiuyitime@fdachem.com China 16512 58
Adachibio Inc.
+81-8027837258; +8108027837258
sales@adachibio.com Japan 938 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21587 55
Shenzhen Nexconn Pharmatechs Ltd
+86-755-89396905 +86-15013857715
admin@nexconn.com China 10403 58
Shanghai Longyu Biotechnology Co., Ltd.

info@longyupharma.com China 2421 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49979 58
career henan chemical co
+86-0371-86658258 +8613203830695
factory@coreychem.com China 29792 58

123246-29-7()Verwandte Suche:


  • Ac-DNal-DCpa-DPal-Ser-Tyr-DHar(Et2)-Leu-Har(Et2)-Pro-DAla -NH2
  • ganirelix Acetate
  • Ganirelixum
  • Ganirelix Acetate USP/EP/BP
  • Ganirelix Impurity 1
  • Ganirelix Acetate API
  • 3-?bis[[3-?(3
  • 4-?dihydroxyphenyl)?-?1-?oxo-?2-?propen-?1-?yl]?oxy]?-?4
  • 5-?dihydroxy-
  • Ganirelix DiAcetate
  • GANIRELIX
  • 123246-29-7
  • 23246-29-7
  • C80H113ClN18O13
  • hormones
Copyright 2019 ? ChemicalBook. All rights reserved
闸北区| 巩留县| 西丰县| 寻乌县| 西畴县| 昌邑市| 建水县| 定南县| 化州市| 新乐市| 红河县| 安溪县| 巴青县| 洮南市| 金阳县| 拉萨市| 济源市| 朝阳县| 芜湖市| 长岛县| 长治市| 海晏县| 太谷县| 宜昌市| 扬州市| 乳山市| 蒙城县| 临猗县| 景洪市| 交城县| 堆龙德庆县| 雷州市| 云林县| 余庆县| 阜宁县| 六安市| 望谟县| 宜春市| 德兴市| 井陉县| 鹤山市|